A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF) in the population aged 65 years and over, as well as its prevalence and incidence in this age group. Also to evaluate the relative cost-effectiveness of different methods of recording and interpreting the electrocardiogram (ECG) within a screening programme. DESIGN: Multicentred randomised controlled trial. Purposefully selected general practices were randomly allocated to 25 intervention practices and 25 control practices. SETTING: Fifty primary care centres across the West Midlands, UK. PARTICIPANTS: Patients aged 65 years and over. INTERVENTIONS: GPs and practice nurses in the intervention practices received education on the importance of AF detection and ECG interpretation. Patients in the intervention practices were randomly allocated to systematic (n = 5000) or opportunistic screening (n = 5000). Prospective identification of pre-existing risk factors for AF within the screened population enabled comparison between targeted screening of people at higher risk of AF and total population screening. MAIN OUTCOME MEASURES: AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared with AF detection rate in 5000 patients in the control practices. The screening period was 12 months. RESULTS: Baseline prevalence of AF was 7.2%, with a higher prevalence in males (7.8%) and patients aged 75 years and over (10.3%). The control population demonstrated higher baseline prevalence (7.9%) than either the systematic (6.9%) or opportunistic (6.9%) intervention population. In the control population 47 new cases were detected (incidence 1.04% per year). In the opportunistic arm 243 patients without a baseline diagnosis of AF were found to have an irregular pulse, with 177 having an ECG, yielding 31 new cases (incidence 0.69% per year). A further 44 cases were detected outside the screening programme (overall incidence 1.64% per year). In the systematic arm 2357 patients had an ECG yielding 52 new cases (incidence 1.1% per year). Of these, 31 were detected by targeted screening and a further 21 by total population screening. A further 22 cases were detected outside the screening programme (overall incidence 1.62% per year). In terms of ECG interpretation, computerised decision support software (CDSS) gave a sensitivity of 87.3%, a specificity of 99.1% and a positive predictive value (PPV) of 89.5% compared with the gold standard (cardiologist reporting). GPs and practice nurses performed less well. The only difference in performance between intervention populations and controls was that practice nurses from the control arm performed less well than with intervention practice nurses on interpretation of limb-lead (PPV 38.8% versus 20.8%) and single-lead (PPV 37.7% versus 24.0%) ECGs. The within-trial economic evaluation results showed the lowest incremental cost to be for the opportunistic arm, with an incremental cost-effectiveness ratio of 337 pounds Sterling for each additional case detected compared to the control arm. Opportunistic screening dominated both more intensive screening strategies. Model-based analyses showed small differences in cost and quality-adjusted life-years for different methods and intensities of screening, but annual opportunistic screening resulted in the lowest number of ischaemic strokes and greatest proportion of cases of AF diagnosed. Probabilistic sensitivity results indicated that there was a probability of approximately 60% that screening from the age of 65 years was cost-effective in both men and women. CONCLUSIONS: The results of the study indicated that in terms of a screening programme for atrial fibrillation in patients 65 and over, the only strategy that improved on routine practice was opportunistic screening, model-based analyses indicated that there was a probability of approximately 60% of annual opportunistic screening being cost effective. It is suggested that the following topics are worthy of further investigation: the effect of the implementation of a screening programme for AF on the uptake and maintenance of anticoagulation in patients aged 65 years and over; an evaluation of the role of CDSS in the diagnosis of cardiac arrythmias; the best method for routinely detecting paroxysmal AF; ways of improving healthcare professionals' performance in ECG interpretation; development of a robust economic model to incorporate data on new therapeutic agents for use as thromboprophylactic agents for patients with AF, and an evaluation of the relative risk of stroke for patients with incident as opposed to prevalent AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“reports of other screening instruments have suggested minimal burden and disruption of the clinical workflow.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [460]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A data monitoring committee will often comprise members from a variety of disciplines.363 451 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
Experimental — accuracy not yet measuredIn the citing paper
“Blinding of data monitoring committee members is generally discouraged.363”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Independence, particularly from the sponsor and trial investigators, is a key characteristic of the data monitoring committee and can be broadly defined as the committee comprising members who are “completely uninvolved in the running of the trial and who cannot be unfairly influenced (either directly or indirectly) by people, or institutions, involved in the trial.”363 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Opportunistic screening for silent AF seems cost-effective in elderly populations (e.g.> 65 years), 131 and similar effects have been reported using single-lead ECG screening in other at-risk populations.132,133”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Marteau, T. M., & Bekker, H. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00997.x · Cited by 3,238
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
Research works printed but not linked: 16
- [10]10. Lake RR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med 1989;19:321-6.
- [11]11. Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59.
- [15]15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
- [19]19. Laupacis A, Albers G, Connolly S. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
- [23]23. Albers GW. Atrial fibrillation and stroke. Arch Intern Med 1994;154:1443-8.
- [24]24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke References Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
- [34]34. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomised trials. Arch Intern Med 1997;157:1237-40.
- [35]35. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med 1992;116:6-12.
- [38]38. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness analysis in medicine and health. Oxford: Oxford University Press; 1996.
- [41]41. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
- [44]44. Hobbs FDR. Should all patients with atrial fibrillation be assessed by a cardiologist? Plenary session. Proceedings from Consensus Conference on the Management of Atrial Fibrillation. Edinburgh: RCP Edinburgh; 1998.
- [57]57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer MD. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
- [60]60. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6. J Neurol Neurosurg Psychiatry 1990;53:16-22.
- [63]63. Office for National Statistics. Health Statistics Quarterly, 22. London: Office for National Statistics; 2004.
- [67]67. Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes. Journal of Health Services and Research Policy 2001;6:92-8. References
- [73]73. Gray JAM. Dimensions and definitions of screening. Milton Keynes: NHS Executive Anglia; Oxford: Research and Development Directorate; 1996.
Cited by
Items 201–300 of 437
Systematic Screening for Atrial Fibrillation in the Community: Evidence and Obstacles
Chan, N. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.47.2 · Cited by 20
Prevention of cardiovascular diseases
Hobbs, R. F. (2015) · BMC Medicine · doi:10.1186/s12916-015-0507-0 · Cited by 16
Blanco, V. G., de Torres, L. Á. P., Rioboó, E. M., Adell, M. Á. M., Rejano, J. M. P., González-Lama, J., Moruno, J. R., Álvarez, R. M., García, J., de Castroviejo, J. R., et al. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.07.036 · Cited by 16
Guo, J. D., Gehchan, A., & Hartzema, A. G. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091961 · Cited by 16
Assessment and Management of Atrial Fibrillation in Older Adults with Frailty
Diaz, A. N. R., Troy, A. L., Kaplinskiy, V., Pritchard, A., Vani, R., Ko, D., & Orkaby, A. R. (2024) · Geriatrics · doi:10.3390/geriatrics9020050 · Cited by 22
“Studies have demonstrated that multiple screening approaches increase the diagnosis of asymptomatic AF [44–47].”
BackgroundEpidemiología de la fibrilación auricular
Gómez‐Doblas, J. J., López-Garrido, M. A., Ruiz, I. E., & Barón‐Esquivias, G. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30007-3 · Cited by 46
Outcome of left atrial appendage occlusion in high-risk patients
Masoud, A. T., Bartoletti, S., Fairbairn, T. A., Khurana, A., Velavan, P., Morrison, W. L., Khalatbari, A., Aggarwal, S. K., Sharma, N., Kirchhof, P. F., et al. (2017) · Heart · doi:10.1136/heartjnl-2017-312383 · Cited by 15
Monteiro, P. F. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.08.006 · Cited by 15
To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation
Neubeck, L., Orchard, J. J., Lowres, N., & Freedman, S. B. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.118 · Cited by 23
Veale, E. L., Stewart, A. J., Mathie, A. A., Lall, S. K., Rees-Roberts, M., Savickas, V., Bhamra, S. K., & Corlett, S. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021121 · Cited by 15
Management of Atrial Fibrillation
Watson, T., & Lip, G. Y. H. (2006) · Herz · doi:10.1007/s00059-006-2932-5 · Cited by 16
“dressed in the SAFE study (Screening for Atrial Fibrillation in the agEd) [ 9 ], which was a study to determine the most cost-effective method of screening for AF in the population aged ≥ 65 years, as well as its prevalence and incidence in this age group.”
Self-citationCooper, J., Nirantharakumar, K., Crowe, F. L., Azcoaga-Lorenzo, A., McCowan, C., Jackson, T., Acharya, A., Gokhale, K. M., Gunathilaka, N. J., Marshall, T. P., et al. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02296-z · Cited by 16
Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?
Orchard, J. J., Lowres, N., Neubeck, L., & Freedman, B. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy156 · Cited by 17
Prevalence of Atrial Fibrillation Subtypes in Italy and Projections to 2060 for Italy and Europe
Carlo, A. D., Zaninelli, A., Mori, F., Consoli, D., Bellino, L., Baldereschi, M., Sgherzi, B., Gradia, C., D’Alfonso, M. G., Cattarinussi, A., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16748 · Cited by 17
“A 12-lead ECG read by a cardiologist is recognized as the gold standard for the diagnosis of AF.(29) For all subjects with a positive screening, a 12-lead ECG at rest was recorded and digitally stored at each practice, using My CardioPad XL ECG Recorder (Esaote).”
MethodAtrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?
Orchard, J. J., Lowres, N., Neubeck, L., & Freedman, B. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy111 · Cited by 16
Meschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15
Beerten, S. G., Proesmans, T., & Vaes, B. (2021) · JMIR Formative Research · doi:10.2196/24461 · Cited by 16
“Holter measurements and event recorders could partially remedy this issue, but interpretation is again very time-consuming and unlikely to be very cost-effective [10].”
BackgroundAtrial Fibrillation and Hypertension: “Quo Vadis”
Kwon, Y., Walker, M., Patel, P., Kwon, O., Koene, R. J., & Duprez, D. A. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220112122403 · Cited by 18
Salvatori, V., Becattini, C., Laureti, S., Baglioni, G., Germini, F., Grilli, P., Guercini, F., Filippucci, E., & Agnelli, G. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1241-5 · Cited by 15
(2006) · Clinical Governance An International Journal · doi:10.1108/cgij.2006.24811baf.002 · Cited by 14
Is it possible to detect atrial fibrillation by simply using RR intervals
Hargittai, S. (2014) · Cited by 13
Pennington, B. R. T., Colquhoun, D. A., Neuman, M. D., Politi, M. C., Janda, A. M., Spino, C., Thelen-Perry, S., Wu, Z., Kumar, S. S., Gregory, S. H., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070096 · Cited by 16
Twigg, M. J., Thornley, T., & Scobie, N. N. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0303-8 · Cited by 15
“This aligns closely with figures comparing no screening with opportunistic and systematic screening, which indicates that an opportunistic approach may be more cost effective for identifying cases of AF [9].”
BackgroundAutomated detection of atrial fibrillation based on vocal features analysis
Golovchiner, G., Glikson, M., Swissa, M., Sela, Y., Abelow, A., Morelli, O., & Beker, A. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15595 · Cited by 14
Berman, A. E., Kabiri, M., Wei, T., Galvain, T., Sha, Q., & Kück, K. (2023) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.122.011237 · Cited by 14
Patel, S., French, A., Mathias, H., Lyen, S. M., Hamilton, M. C. K., & Manghat, N. E. (2013) · Clinical Radiology · doi:10.1016/j.crad.2013.02.005 · Cited by 14
Matsumoto, K., Jin, Z., Homma, S., Elkind, M. S. V., Schwartz, J. E., Rundek, T., Mannina, C. M., Ito, K., Sacco, R. L., & Tullio, M. R. D. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002613 · Cited by 13
Willits, I., Keltie, K., Linker, N. J., de Belder, M., Henderson, R. A., Patrick, H. E., Powell, H., Berry, L., Urwin, S., Cole, H., et al. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab042 · Cited by 14
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586 · Cited by 13
Lindsberg, P. J., Toivonen, L. K., & Diener, H. (2014) · BMC Medicine · doi:10.1186/s12916-014-0180-8 · Cited by 15
Cole, J. N., Torabi, P., Dostal, I., Homer, K., & Robson, J. P. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x696605 · Cited by 12
Bacchini, M., Bonometti, S., Zotti, F. D., Lechi, A., Realdon, F., Fava, C., & Minuz, P. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00334-4 · Cited by 14
Engdahl, J., Holmén, A., Rosenqvist, M., & Strömberg, U. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-715 · Cited by 12
Zwar, N. A., Dennis, S. M., Griffiths, R., Perkins, D. A., May, J., Sibbald, B., Caplan, G., & Harris, M. (2007) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/381 · Cited by 19
Engler, D., Hanson, C. L., Desteghe, L., Boriani, G., Diederichsen, S. Z., Freedman, B., Palà, E., Potpara, T., Witt, H., Heidbüchel, H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059156 · Cited by 13
Cost-effectiveness of atrial fibrillation screening in Canadian community practice
Andrade, J. G., Shah, A., Godin, R., Lanitis, T., Kongnakorn, T., Brown, L., Dhanda, D. S., Dhamane, A. D., & Nault, I. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.11.003 · Cited by 10
“Both interventional groups identified significantly more newAF cases compared to usual care; however, only opportunistic case finding was found to be cost-effective.(34)”
BackgroundAnticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
Brimble, K. S., Ingram, A. J., Eikelboom, J. W., & Hart, R. G. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2609 · Cited by 12
Khurshid, S. S., Chen, W., Singer, D. E., Atlas, S. J., Ashburner, J. M., Choi, J., Hur, C., Ellinor, P. T., McManus, D. D., Chhatwal, J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020330 · Cited by 13
Five-year results of Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation
Sharples, L. D., Mills, C., Chiu, Y., Fynn, S. P., Holcombe, H., & Nashef, S. A. M. (2022) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezac181 · Cited by 11
Atrial fibrillation (chronic).
Lane, D. L., Apostolakis, S. Z., Boos, C. J., & Lip, G. Y. H. (2008) · Europe PMC (PubMed Central) · Cited by 12
Self-citationSegan, L. A., Ho, W. W. H., Crowley, R. F., William, J., Cho, K. K., Prabhu, S., Chieng, D., Sugumar, H., Voskoboinik, A., Ling, L., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.04.032 · Cited by 12
Blood pressure in patients with atrial fibrillation: part 2—treatment
Cohen, D. L., & Townsend, R. R. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12939 · Cited by 11
Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage
Demir, N. (2019) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2019.76993 · Cited by 10
Paroxysmal atrial fibrillation
Gahungu, N., Trueick, R., Coopes, M., & Gabbay, E. (2021) · BMJ · doi:10.1136/bmj-2021-058568 · Cited by 10
Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.
Cortés, G. M., Sandoval, M. E. V., Martínez, C. A. A., Vega-Gómez, H. E., Castañeda, S. E. L., & García, A. G. (2014) · PubMed Central · doi:10.4022/jafib.1124 · Cited by 10
20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation
Ntaios, G., Sagris, D., Gioulekas, F., Galanis, P., Pardali, C., Vemmou, A., Korompoki, E., Papavasileiou, V., Vassilopoulou, S., Manios, E. D., et al. (2018) · International Journal of Stroke · doi:10.1177/1747493018772722 · Cited by 11
Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening
Gudmundsdottir, K. K., Fredriksson, T., Svennberg, E., Al‐Khalili, F., Friberg, L., Häbel, H., Frykman, V., & Engdahl, J. (2021) · Clinical Cardiology · doi:10.1002/clc.23595 · Cited by 9
Poorthuis, M. H. F., Sherliker, P., de Borst, G. J., Clack, R. M., Lewington, S., Clarke, R., Bulbulia, R. A., & Halliday, A. W. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131262 · Cited by 10
Atrial Fibrillation in the Intensive Care Setting
Malik, A., Candilio, L., & Hausenloy, D. J. (2013) · Journal of the Intensive Care Society · doi:10.1177/175114371301400212 · Cited by 10
Khoo, C. W., & Lip, G. Y. H. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902910443 · Cited by 10
Self-citationHarwood, R., Goldberg, S. E., Brand, A., van der Wardt, V., Booth, V., Lorito, C. D., Hoare, Z., Hancox, J. E., Bajwa, R. K., Burgon, C., et al. (2022) · medRxiv · doi:10.1101/2022.12.20.22283699 · Cited by 10
Cost-Effectiveness of Screening to Identify Patients With Atrial Fibrillation: A Systematic Review
Halahakone, U., Senanayake, S. J., McCreanor, V., Parsonage, W. A., Kularatna, S., & Brain, D. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.03.014 · Cited by 11
Anagnostopoulos, I., Kousta, M. S., Vrachatis, D. A., Giotaki, S. G., Katsoulotou, D., Karavasilis, C., Schizas, N. C., Avramides, D., Γιαννόπουλος, Γ., & Deftereos, S. G. (2024) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2024.2432579 · Cited by 9
“Nevertheless, it is highlighted that aggressive screening programs may be associated with false positive results and significant costs [41].”
Francisco, A., Pascoal, C., Lamborne, P., Morais, H., & Gonçalves, M. A. D. A. (2025) · Cureus · doi:10.7759/cureus.77404 · Cited by 29
Blood Pressure in Patients With Atrial Fibrillation: Part 1––Measurement
Cohen, D. L., & Townsend, R. R. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12905 · Cited by 10
Sciera, L. K., Frost, L., Dybro, L., & Poulsen, P. B. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa092 · Cited by 9
Stevenson, M., Simpson, E. L., Rawdin, A., & Papaioannou, D. E. (2010) · Journal of Simulation · doi:10.1057/jos.2009.12 · Cited by 9
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016) · F1000Research · doi:10.12688/f1000research.10176.1 · Cited by 10
“The suggestion of widespread screening for AF is not new, with previous studies within community healthcare practices and meta-analyses showing a clear benefit 24 .”
ResultSelf-citationLea, W., Budworth, L., O'Hara, J. K., Vincent, C. A., & Lawton, R. (2025) · BMJ Quality & Safety · doi:10.1136/bmjqs-2024-017926 · Cited by 7
Desteghe, L., Lee, G., Antoniou, S., Merino, J. L., Neubeck, L., Ross, C., Svennberg, E., & Hendriks, J. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaf083 · Cited by 10
Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population
Palareti, G., Salomone, L., Cavazza, M., Guidi, M., Muscari, A., Boriani, G., Micoli, A. D., Guizzardi, G., Procaccianti, G., Guidetti, A. M., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2443 · Cited by 8
Self-citationRetrospective cohort study highlighted outcome reporting bias in UK publicly funded trials
Matthews, G. A., Dumville, J. C., Hewitt, C. E., & Torgerson, D. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.03.013 · Cited by 8
Tang, W., Chang, Y.-J., Chen, Y. J., & Ho, W. (2018) · Computers & Electrical Engineering · doi:10.1016/j.compeleceng.2018.03.019 · Cited by 8
Gahungu, N., Judkins, C., Gabbay, E., & Playford, D. A. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.01.036 · Cited by 7
Lichten, C. A., Castle‐Clarke, S., Manville, C. M., Horváth, V., Robin, E., Krapels, J., Parks, S., Sim, M., van Zijverden, O., & Chataway, J. (2015) · Rand health quarterly · doi:10.7249/rhq-05-02-02 · Cited by 11
Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation.
Ali, A., Athavale, N. V., & Abdelhafiz, A. H. (2016) · PubMed · doi:10.4022/jafib.1366 · Cited by 10
Wahler, S., Birkemeyer, R., Alexopoulos, D. K., Siudak, Z., Müller, A., & von der Schulenburg, J.-M. (2022) · Health Economics Review · doi:10.1186/s13561-022-00362-2 · Cited by 8
Slow Heart Rate Predicts New Occurrence of Atrial Fibrillation
Hai, J. J., Chan, P., Tse, H., & Siu, C. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.04.185 · Cited by 8
Upstream Therapy for Atrial Fibrillation in Heart Failure
Goette, A. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.010 · Cited by 9
Blanco, V. G., de Torres, L. Á. P., Rioboó, E. M., Adell, M. Á. M., Rejano, J. M. P., González-Lama, J., Moruno, J. R., Álvarez, R. M., García, J., de Castroviejo, J. R., et al. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.07.029 · Cited by 8
Boulos, M. N. K., & Haywood, G. A. (2021) · mHealth · doi:10.21037/mhealth-19-204 · Cited by 10
Denas, G., Battaggia, A., Fusello, M., Novelletto, B. F., Cancian, M., Scalisi, A., & Pengo, V. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.097 · Cited by 8
Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
Touchette, D. R., McGuinness, M. E., Stoner, S., Shute, D., Edwards, J. M., & Ketchum, K. L. (2008) · Pharmacy Practice · doi:10.4321/s1886-36552008000100007 · Cited by 9
Caldwell, J. C., Borbas, Z., Donald, A., Clifford, A. G., Bolger, L. E., Black, A. L., Corden, J., & Fitzpatrick, A. P. (2011) · EP Europace · doi:10.1093/europace/eur304 · Cited by 8
Wong, K. C., Nguyen, T. N., & Chow, C. K. (2024) · npj Cardiovascular Health · doi:10.1038/s44325-024-00014-w · Cited by 11
Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study
Khan, M., Ingre, M., Carlstedt, F., Eriksson, A., Skröder, S., Tenn, J. S., Rosenqvist, M., & Svennberg, E. (2024) · EP Europace · doi:10.1093/europace/euae234 · Cited by 7
Pennington, B. R. T., Janda, A. M., Colquhoun, D. A., Neuman, M. D., Kidwell, K., Spino, C., Thelen-Perry, S., Krambrink, A., Huang, S., Ignacio, R., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103836 · Cited by 7
Chen, Y., Hung, C., Huang, C., Hung, Y., Hwang, J., & Ho, Y. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.8290 · Cited by 7
“Previously, undiagnosed AF was found in 1.4% of those aged >65 years, which suggests that opportunistic screening for silent AF may be cost-effective in elderly populations [17].”
InfluentialSilent Atrial Fibrillation: Clinical Management and Perspectives
Guénancia, C., Garnier, F., Fichot, M., Sagnard, A., Laurent, G., & Lorgis, L. (2020) · Future Cardiology · doi:10.2217/fca-2019-0066 · Cited by 7
Xu, G., Xiao, Q., Lei, H., Fu, Y., Kong, J., Zheng, Q., Zhao, L., & Liang, F. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034152 · Cited by 7
Prevalence of atrial fibrillation
Samim, D., Choffat, D., Vollenweider, P., Waeber, G., Marques-Vidal, P. M., & Méan, M. (2021) · Herz · doi:10.1007/s00059-021-05090-7 · Cited by 8
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., Czanner, G., Shaw, A., Smith, E. J., Santos, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040578 · Cited by 7
“Two randomised controlled trials have found that pulse palpation is an effective and cost-effective approach for screening for AF [18,30].”
BackgroundSelf-citationPrimary care research and clinical practice: cardiovascular disease
Mavaddat, N., & Mant, J. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.094771 · Cited by 7
“Patients in active screening practices were further randomised to be invited to attend the practice for systematic screening (at which an ECG was performed) or to opportunistic screening, in which their pulse was taken while attending the practice for another reason (with ECG performed only if the pulse was irregular)…”
Self-citationKirchhof, P. F., Adamou, A., Knight, E., & Lip, G. Y. H. (2009) · Cited by 19
Self-citationDescriptive analysis of pharmacy services provided after community pharmacy screening
Lancaster, K., Thabane, L., Tarride, J., Agarwal, G., Healey, J. S., Sandhu, R. K., & Dolovich, L. R. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0742-5 · Cited by 7
Detection of atrial fibrillation in asymptomatic at-risk individuals
Langer, A., Healey, J. S., Quinn, F. R., Honos, G. N., Nault, I., Tan, M., Camara, D., Newman, D. M., & Godin, R. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.04.048 · Cited by 8
The Economics of Atrial Fibrillation: A Time for Review and Prioritization
Cadilhac, D. A.-M. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00831.x · Cited by 8
Recomendaciones preventivas vasculares. Actualización PAPPS 2024
Orozco‐Beltrán, D., Brotons-Cuixart, C., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Martín-Rioboó, E., Jordá-Baldó, A., Vicuña, J., & Navarro-Pérez, J. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.103123 · Cited by 13
Koide, Y., Kataoka, Y., Hasegawa, T., Ota, E., & Noma, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057768 · Cited by 6
Screening for atrial fibrillation in primary care: From recommendation to implementation
Taggar, J., & Coleman, T. J. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316652976 · Cited by 9
“62% for systematic screening) but economic analyses from this study suggested opportunistic screening was more cost-effective.(10) Based on this trial data, current recommendations assume the optimal configuration for screening is the two-stage approach of pulse palpation followed by confirmatory 12-lead.”
BackgroundDetection of Previously Unrecognized (Subclinical) Atrial Fibrillation
Kochav, S. M., & Reiffel, J. A. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.04.013 · Cited by 7
Hopps, S., & Marcy, T. R. (2009) · The Consultant Pharmacist · doi:10.4140/tcp.n.2009.841 · Cited by 6
Electrocardiography Screening for Atrial Fibrillation
PASSMAN, R. S., & Piccini, J. P. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2200 · Cited by 6
Wahab, A., Nadarajah, R., Larvin, H., Farooq, M., Raveendra, K., Haris, M., Nadeem, U., Joseph, T., Bhatty, A., Wilkinson, C., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101298 · Cited by 11
Self-citationZhang, W., Du, L., Huang, Y., Liu, D., Li, T., & Zheng, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096744 · Cited by 8
Early Detection of Atrial Fibrillation in Community Pharmacies—CRIFAFARMA Study
Valdivieso, M. G., Orozco‐Beltrán, D., López‐Pineda, A., Gil-Guillén, V. F., Quesada, J. A., Carratalá‐Munuera, C., & Nouni-García, R. (2022) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484221078973 · Cited by 5
Riccardo, V. I. O., Giordani, A. S., ALTURKI, A., Čulić, V., VITALE, R., CHINA, P., Themistoclakis, S., Vanoli, E., & PROIETTI, R. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.22.05894-x · Cited by 5
Ó’Caoimh, R., Morrison, L. J., Hanley, M., McManus, C., Donlon, K., & Galvin, P. A. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21030270 · Cited by 5
Atrial Fibrillation Screening in the Elderly
Fu, Y., Chao, T., Yeh, Y., Chan, Y., Chien, H., Chen, S., & Lin, F. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.09.016 · Cited by 7
Suzuki, A., Okamura, T., Sasaki, M., Matsuoka, H., Ikeda, Y., Takahashi, A., Akiyama, S., Ono, F., Yoshihara, N., & The Akita Study group (2020) · PLoS ONE · doi:10.1371/journal.pone.0244240 · Cited by 6
Metadata
- Authors
- Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G.
- Affiliations
- University of Birmingham (GB)
- Selly Oak Hospital (GB)
- Birmingham City Hospital (GB)
- Venue
- Health Technology Assessment
- Published
- 2005-10
- Volume
- 9
- Issue
- 40
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2018796325
- Semantic Scholar
- 6a762d2e553123cd54cf721ab5362f51c0e3da53
- Cited by
- 437
- References
- 60
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 24 · 2023: 17 · 2022: 32 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 34 · 2017: 25 · 2016: 31 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 18
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ePrints Soton (University of Southampton) (submittedVersion)
- Apollo
- Funders
- Health Technology Assessment programme (96/22/11)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, systematic screening, opportunistic screening, targeted screening, cost-effectiveness, ECG interpretation, irregular pulse, atrial fibrillation prevalence, atrial fibrillation incidence, older adults, primary care, atrial fibrillation risk factors, practice nurses, general practitioners, atrial fibrillation mortality
- MeSH terms
- Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, United Kingdom, Humans, Male, Mass Screening, Primary Health Care, Risk Factors, Incidence, Prevalence, Outcome Assessment, Health Care, Sample Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.